U.S. markets close in 3 hours 46 minutes
  • S&P 500

    4,537.67
    +18.04 (+0.40%)
     
  • Dow 30

    35,631.73
    +174.42 (+0.49%)
     
  • Nasdaq

    15,144.29
    +15.20 (+0.10%)
     
  • Russell 2000

    2,293.05
    +17.13 (+0.75%)
     
  • Crude Oil

    83.37
    +0.41 (+0.49%)
     
  • Gold

    1,784.60
    +14.10 (+0.80%)
     
  • Silver

    24.39
    +0.50 (+2.10%)
     
  • EUR/USD

    1.1650
    +0.0012 (+0.10%)
     
  • 10-Yr Bond

    1.6360
    +0.0010 (+0.06%)
     
  • GBP/USD

    1.3822
    +0.0028 (+0.20%)
     
  • USD/JPY

    114.2540
    -0.1060 (-0.09%)
     
  • BTC-USD

    66,686.32
    +4,177.66 (+6.68%)
     
  • CMC Crypto 200

    1,548.73
    +67.92 (+4.59%)
     
  • FTSE 100

    7,223.10
    +5.57 (+0.08%)
     
  • Nikkei 225

    29,255.55
    +40.03 (+0.14%)
     

CLASS ACTION UPDATE for TILE, NERV and QSR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / January 6, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

TILE Shareholders Click Here: https://www.zlk.com/pslra-1/interface-inc-loss-submission-form?prid=11963&wire=1
NERV Shareholders Click Here: https://www.zlk.com/pslra-1/minerva-neurosciences-inc-loss-submission-form?prid=11963&wire=1
QSR Shareholders Click Here: https://www.zlk.com/pslra-1/restaurant-brands-international-inc-loss-submission-form?prid=11963&wire=1

* ADDITIONAL INFORMATION BELOW *

Interface, Inc. (NASDAQ:TILE)

TILE Lawsuit on behalf of: investors who purchased March 2, 2018 - September 28, 2020
Lead Plaintiff Deadline: January 11, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/interface-inc-loss-submission-form?prid=11963&wire=1

According to the filed complaint, during the class period, Interface, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Interface had inadequate disclosure controls and procedures and internal control over financial reporting; (ii) consequently, Interface, inter alia, reported artificially inflated income and earnings per share ("EPS") in 2015 and 2016; (iii) Interface and certain of its employees were under investigation by the SEC with respect to the foregoing issues since at least as early as November 2017, had impeded the SEC's investigation, and downplayed the true scope of the Company's wrongdoing and liability with respect to the SEC investigation; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Minerva Neurosciences, Inc. (NASDAQ:NERV)

NERV Lawsuit on behalf of: investors who purchased May 15, 2017 - November 30, 2020
Lead Plaintiff Deadline: February 8, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/minerva-neurosciences-inc-loss-submission-form?prid=11963&wire=1

According to the filed complaint, during the class period, Minerva Neurosciences, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the truth about the feedback received from the FDA concerning the "end-of-Phase 2" meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company's plan to use the combination of the Phase 2b and Phase 3 studies would be "highly unlikely" to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to "substantial review issues" because the trials were inadequate and not well-controlled; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

Restaurant Brands International Inc. (NYSE:QSR)

QSR Lawsuit on behalf of: investors who purchased April 29, 2019 - October 28, 2019
Lead Plaintiff Deadline: February 19, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/restaurant-brands-international-inc-loss-submission-form?prid=11963&wire=1

According to the filed complaint, during the class period, Restaurant Brands International Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's Winning Together Plan was failing to generate substantial, sustainable improvement within the Tim Hortons brand; (2) the Tims Rewards loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and (3) as a result, Defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
https://www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/623313/CLASS-ACTION-UPDATE-for-TILE-NERV-and-QSR-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders